For the quarter ending 2026-03-31, COCHW made $39K in revenue. -$5,701K in net income. Net profit margin of -14617.95%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Net revenues | 39 | 115* | 42 | |
| Cost of goods sold | 313 | 265* | 203 | |
| Research and development | 3,642 | 4,386* | 2,700 | |
| Sales and marketing | 164 | 5* | 405 | |
| General and administrative | 1,879 | 605* | 2,442 | |
| Total costs and operating expenses | 5,998 | 5,261* | 5,750 | |
| Operating loss | -5,959 | -5,146* | -5,708 | |
| Change in fair value of forward purchase agreement warrant liability | 13 | -970* | -64 | |
| Change in fair value of forward purchase agreement warrant liability due to extension | - | 6* | - | |
| Change in fair value of private warrant liability | - | - | 339 | |
| Loss on offering and change in fair value of private warrant liability | -2,005 | 124* | - | |
| Change in fair value of publicly traded warrant liability | 390 | -210* | 33 | |
| Other income (expense), net | 6 | -38* | 5 | |
| Interest expense (related party) | 0 | 177* | 471 | |
| Total other income (expense), net | 1,608 | 836* | -774 | |
| Net loss | -4,351 | -4,310* | -6,482 | |
| Cumulative preferred dividends | 1,350 | 1,111* | 1,265 | |
| Net loss attributable to common stockholders, basic | -5,701 | -5,421 | -7,747 | |
| Basic EPS | -0.08 | -0.22 | -0.35 | |
| Diluted EPS | -0.08 | -0.22 | -0.35 | |
| Basic Average Shares | 68,934,960 | 24,667,590 | 21,851,606 | |
| Diluted Average Shares | 68,934,960 | 24,667,590 | 21,851,606 | |
Envoy Medical, Inc. (COCHW)
Envoy Medical, Inc. (COCHW)